We are an RNA delivery and therapeutics company. Our proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of organic materials with inorganic bioabsorbable silicon.
Our Bio-Courier portfolio includes silicon stabilized hybrid lipid nanoparticles (sshLNP) that improve the stability, safety, and transfection efficiency of RNA. We use sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and are maximizing the potential of our technology through research partnerships.
Led by founder and leading biomaterials specialist Dr Suzanne Saffie-Siebert, SiSaf is a venture capital backed private company. Headquartered in Guildford, UK, we have fully integrated research labs and bio-analytical facilities, a scalable technology to fast-track development, and a growing patent estate with extensive freedom to operate.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 3 Huxley Road, Guildford,england Gu2 7,united Kingdom
- Phone
- 44 7827 275 663
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sisaf.com
- Keywords
- drug delivery, drug development, Gene Therapy, Drug Reformulation, Corneal Dystrophy, Osteopetrosis, Keloid scars.
- HQ
- Guildford, England
Sisaf Ltd Questions
Sisaf Ltd's helpline number is 44 7827 275 663
Sisaf Ltd's website is sisaf.com
Sisaf Ltd's LinkedIn profile is https://uk.linkedin.com/company/sisaf-ltd
Sisaf Ltd has
20 employees.
View email and phone details for 20
employees at Sisaf Ltd.
Sisaf Ltd's industry is
Biotechnology Research
Sisaf Ltd's top competitors are
Metis Therapeutics,
Threebrooks Therapeutics Inc,
Hopewell Therapeutics, Inc.,
Notch Therapeutics,
Medpharm,
Integrated Nanotherapeutics Inc.,
Nanite,
Tenvie Therapeutics,
Lysoway Therapeutics,
Nanovation Therapeutics™.
Sisaf Ltd's categories are Biotechnology Research
Sisaf Ltd's founding year is 2008
